| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/24/2010 | US20100160297 Compounds for pim kinase inhibition and for treating malignancy |
| 06/24/2010 | US20100160296 Use of imipramine blue and analogs thereof in treating cancers |
| 06/24/2010 | US20100160295 Treatment of restless leg syndrome and sleep disorders |
| 06/24/2010 | US20100160294 Tolerability of mirtazapine and a second active by using them in combination |
| 06/24/2010 | US20100160293 Solid Ophthalmic Drug for External Use |
| 06/24/2010 | US20100160292 Kinase Inhibitors, and Methods of Using and Identifying Kinase Inhibitors |
| 06/24/2010 | US20100160291 Tricyclic spiro-oxindole derivatives and their uses as therapeutic agents |
| 06/24/2010 | US20100160290 Pharmaceutical composition for treating alzheimer's disease |
| 06/24/2010 | US20100160289 Sulfonamides as trpm8 modulators |
| 06/24/2010 | US20100160288 Purine Compounds |
| 06/24/2010 | US20100160287 Compounds useful as inhibitors of janus kinases |
| 06/24/2010 | US20100160286 Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes |
| 06/24/2010 | US20100160285 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease |
| 06/24/2010 | US20100160284 Carbapenem antibacterials with gram-negative activity and processes for their preparation |
| 06/24/2010 | US20100160283 Heteroaryl-substituted alkyne compounds and method of use |
| 06/24/2010 | US20100160282 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 06/24/2010 | US20100160281 Monocarbams |
| 06/24/2010 | US20100160280 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors |
| 06/24/2010 | US20100160279 Azetidine Derivatives as Muscarinic Receptor Antagonists |
| 06/24/2010 | US20100160278 Stabilized freeze-dried formulation for cephalosporin derivatives |
| 06/24/2010 | US20100160277 Compositions for combating beta-lactamase-medicated antibiotic resistance using beta-lactamase inhibitors useful for injection |
| 06/24/2010 | US20100160276 Synthetic bile acid compositions and methods |
| 06/24/2010 | US20100160275 Methods and compositions for cancer prevention and treatment |
| 06/24/2010 | US20100160274 7-KETO DHEA for Psychiatric Use |
| 06/24/2010 | US20100160273 Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues |
| 06/24/2010 | US20100160272 Oxepine modulators of h1 receptors and/or inhibitors of mast cell degranulation |
| 06/24/2010 | US20100160271 Bicyclic modulators of h1 receptors |
| 06/24/2010 | US20100160270 Use of testosterone and a 5-ht1a agonist in the treatment of sexual dysfunction |
| 06/24/2010 | US20100160269 Use of N-(dibenz(B,F)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine or a pharmaceutically acceptable addition salt thereof for the prophylaxis and/or treatment of muscular dystrophy |
| 06/24/2010 | US20100160268 Isoflavonoid Analogs and their Metal Conjugates as Anti-Cancer Agents |
| 06/24/2010 | US20100160267 Treatment of Inflammatory Bowel Disease With 2-Methylene-19-Nor-Vitamin D Compounds |
| 06/24/2010 | US20100160266 Organic compounds |
| 06/24/2010 | US20100160265 7-(1,4-dioxenyl) doxycycline; Therapy against tetracycline-resistant organisms; bactericides; bacteriostats; escherichia; straphococcus; enterococcus; anticancer agents; antidiabetic agents |
| 06/24/2010 | US20100160264 Crystalline solid forms |
| 06/24/2010 | US20100160263 7,9-substituted tetracycline compounds |
| 06/24/2010 | US20100160262 Compositions and methods for modulating sirtuin activity |
| 06/24/2010 | US20100160261 Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof |
| 06/24/2010 | US20100160260 TRBD-Binding Effectors and Methods for Using the Same to Modulate Telomerase Activity |
| 06/24/2010 | US20100160259 Dosage regimen for a s1p receptor agonist |
| 06/24/2010 | US20100160258 Bicyclic aryl sphingosine 1-phosphate analogs |
| 06/24/2010 | US20100160257 Use of hdac inhibitors for the treatment of myeloma |
| 06/24/2010 | US20100160256 Indazole compounds |
| 06/24/2010 | US20100160255 Spiro-cyclic compound |
| 06/24/2010 | US20100160254 Cellulose Sulfate for the Treatment of Rhinovirus Infection |
| 06/24/2010 | US20100160253 Sulphated xylans for treatment or prophylaxis of respiratory diseases |
| 06/24/2010 | US20100160252 Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization |
| 06/24/2010 | US20100160250 Method for treating inflammatory conditions |
| 06/24/2010 | US20100160248 Isotopically modified compounds and their use as food supplements |
| 06/24/2010 | US20100160247 Synthesis of deuterated morpholine derivatives |
| 06/24/2010 | US20100160246 Microspheres for treatment of brain tumors |
| 06/24/2010 | US20100160245 Quercetin-Containing Compositions |
| 06/24/2010 | US20100160244 Methods and compositions for enhancing collagen, proteoglycan, and glutathione synthesis in the skin |
| 06/24/2010 | US20100160243 Compounds and methods for enhancing erythropoiesis |
| 06/24/2010 | US20100160240 Treatment for epilepsy |
| 06/24/2010 | US20100160233 Antitumour combinations containing a vegf inhibiting agent and irinotecan |
| 06/24/2010 | US20100160228 Method for inhibiting or stimulating angiogenesis in an individual |
| 06/24/2010 | US20100160227 Signaling peptides |
| 06/24/2010 | US20100160224 Shelf-stable consumable compositions containing probiotic-mimicking elements and methods of preparing and using the same |
| 06/24/2010 | US20100160221 Effect of tula on hiv |
| 06/24/2010 | US20100160216 Enhanced transport using membrane disruptive agents |
| 06/24/2010 | US20100160208 Pharmaceutical composition |
| 06/24/2010 | US20100160207 Feedback Prodrug |
| 06/24/2010 | US20100159593 Transfection reagents |
| 06/24/2010 | US20100159453 Genes involved in intestinal inflammatory diseases and use thereof |
| 06/24/2010 | US20100159439 Method for combined sequential agent delivery and electroporation for cell structures and use thereof |
| 06/24/2010 | US20100159046 Minimal tissue attachment implantable materials |
| 06/24/2010 | US20100159043 Extract of the family dioscoreaceae and composition for preventing or treating peripheral neuropathy comprising the same |
| 06/24/2010 | US20100159035 Kit for treating skin infection |
| 06/24/2010 | US20100159034 Pyrrolidinone inhibitors of pde-4 |
| 06/24/2010 | US20100159033 Benzisoxazole modulators of d2 receptor, and/or 5-ht2a receptor |
| 06/24/2010 | US20100159032 Combinations useful for the treatment of neuronal disorders |
| 06/24/2010 | US20100159031 Nail fungus treatment and composition |
| 06/24/2010 | US20100159030 Methods for detecting and modulating the sensitivity of tumor cells to anti-mitotic agents and for modulating turmorgenicity |
| 06/24/2010 | US20100159026 Colonic purgative composition with soluble binding agent |
| 06/24/2010 | US20100159021 Small Molecule Ligands of the Integrin RGD Recognition Site and Methods of Use |
| 06/24/2010 | US20100159020 Polymeric micelles for drug delivery |
| 06/24/2010 | US20100159018 Venlafaxine Formulations and Methods of Preparing the Same |
| 06/24/2010 | US20100159015 Systems and Methods to Treat Pain Locally |
| 06/24/2010 | US20100159014 Polymeric micellar clusters and their uses in formulating drugs |
| 06/24/2010 | US20100159012 Conjugates of Therapeutically Active Compounds |
| 06/24/2010 | US20100159011 Compositions For Biomedical Applications |
| 06/24/2010 | US20100159009 Controlled-release formulations |
| 06/24/2010 | US20100159007 Pharmaceutical compositions for transmucosal delivery of a therapeutically active agent on the basis of submicron particles |
| 06/24/2010 | US20100159005 COMBINATION OF TRIAZINE DERIVATIVES AND PPARalpha AGONISTS |
| 06/24/2010 | US20100159004 Methods and compositions for reduction of side effects of therapeutic treatments |
| 06/24/2010 | US20100159003 Process for the preparation of a medicament comprising vardenafil hydrochloride trihydrate |
| 06/24/2010 | US20100159002 Dosage form comprising therapeutic formulation |
| 06/24/2010 | US20100159000 Medicine for treating gastrointestinal disorder including fecal incontinence |
| 06/24/2010 | US20100158999 Combination of triazine derivatives and hmg-coa reductase inhibitors |
| 06/24/2010 | US20100158998 Formulations comprising vitamin d or derivatives thereof |
| 06/24/2010 | US20100158996 Ester compound and medical use thereof |
| 06/24/2010 | US20100158994 Nanoparticles for Delivery of Therapeutic Agents Using Ultrasound and Associated Methods |
| 06/24/2010 | US20100158993 Topical Gel Compositions |
| 06/24/2010 | US20100158992 Piperazine-substituted pyridazinone derivatives useful as glucan synthase inhibitors |
| 06/24/2010 | US20100158990 Transdermal method and patch for corticosteroid administration |
| 06/24/2010 | US20100158981 Block Biodegradable Copolymers for Medical Devices |
| 06/24/2010 | US20100158974 Coated implant |
| 06/24/2010 | US20100158973 Therapeutic uses of cannabidiol compounds |
| 06/24/2010 | US20100158969 Flexible implantable composites and implants comprising same |
| 06/24/2010 | US20100158959 Stable Combinations of Amlodipine Besylate and Benazepril Hydrochloride |